Cash Flow from Operating Activities: A company's cash flows from operations.
Protalix BioTherapeutics, Inc. (PLX) had Cash Flow from Operating Activities of $-10.29M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$15.66M |
|
$0.16M |
|
$5.87M |
|
$9.79M |
|
$14.49M |
|
$1.17M |
|
$-0.51M |
|
$0.66M |
|
$0.66M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$1.17M |
|
$1.53M |
|
78.66M |
|
81.27M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$65.48M |
|
$4.75M |
|
$13.00M |
|
$78.49M |
|
$24.09M |
|
-- |
|
$4.49M |
|
$28.58M |
|
$49.90M |
|
$49.90M |
|
$49.90M |
|
79.73M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-10.29M |
$-0.75M |
|
$9.18M |
|
$19.76M |
|
$17.89M |
|
$-1.86M |
|
$0.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.51% |
|
7.49% |
|
7.49% |
|
-- |
|
4.22% |
|
1.05% |
|
$-11.03M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.28 |
|
1.66 |
|
54.28 |
|
0.33% |
|
0.33% |
|
0.21% |
|
0.33% |
|
$0.63 |
|
$-0.14 |
|
$-0.13 |
|